Literature DB >> 17160101

Contribution of the regional drug information center towards drug safety.

S Palaian1, P Mishra, P R Shankar, D Bista, B Purwar.   

Abstract

Drug related complications may lead to huge economic impact and cause significant morbidity and mortality. The present study analyzed the services provided by our Drug Information Center (DIC) in relation to drug safety. Over a period of one year, the DIC received 336 drug related queries. Among these 127 queries were related to drug safety. Medical doctors asked 78% of queries and patient care was the purpose behind 64.6% of them. Half (50%) of the enquirers submitted their queries to the center personally or contacted the DIC staff. Forty one percentage of the queries were related to the causality of particular drug towards adverse drug reactions and 10 % regarding drug use in pregnancy and lactation. Centrally acting drugs accounted for 21% of the queries. Twenty two percentage of the enquirers required an immediate answer. DICs by providing unbiased and objective information can reduce the occurrences of drug related complications.

Entities:  

Mesh:

Year:  2006        PMID: 17160101

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.406


  5 in total

1.  Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences.

Authors:  P Ravi Shankar; Baburam Humagain; R M Piryani; Nisha Jha; Bidur Osti
Journal:  Pharm World Sci       Date:  2008-12-05

2.  Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports.

Authors:  Christine Njuguna; Annemie Stewart; Johannes P Mouton; Marc Blockman; Gary Maartens; Annoesjka Swart; Briony Chisholm; Jackie Jones; Mukesh Dheda; Ehimario U Igumbor; Karen Cohen
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

3.  Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal.

Authors:  Sunil Shrestha; Krisha Danekhu; Bhuvan Kc; Subish Palaian; Mohamed Izham Mohamed Ibrahim
Journal:  Ther Adv Drug Saf       Date:  2020-06-12

4.  Evaluation of drug promotional materials in a hospital setting in Nepal.

Authors:  Kadir Alam; Anil Kumar Shah; Pradip Ojha; Subish Palaian; Pathiyil Ravi Shankar
Journal:  South Med Rev       Date:  2009-04-16

5.  Health professionals' knowledge, attitude and practices towards pharmacovigilance in Nepal.

Authors:  Subish Palaian; Mohamed I Ibrahim; Pranaya Mishra
Journal:  Pharm Pract (Granada)       Date:  2011-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.